IU researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy
Jun 24
1 min read
Indiana University School of Medicine cancer researchers have identified a potential way to use existing, accessible drugs to combat juvenile myelomonocytic leukemia (JMML) by targeting a specific inflammatory pathway.
Read more: https://firstwordpharma.com/story/7627533